Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma.
Jun WenXiang ZhangChi Chun WongYating ZhangYasi PanYunfei ZhouAlvin Ho-Kwan CheungYali LiuFenfen JiXing KangDabin LiuJun YuPublished in: Gut (2024)
T cell function and augmenting immunosuppressive MDSCs. SQLE is a promising target in boosting anti-PD-1 immunotherapy for MASH-HCC.